Suppr超能文献

自然杀伤细胞在肝纤维化中的抗纤维化作用。

The antifibrotic role of natural killer cells in liver fibrosis.

机构信息

Department of Hepatology, The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine, Changsha 410000, China.

Department of Gastroenterology, Heilongjiang Academy of Traditional Chinese Medicine, Harbin 150001, China.

出版信息

Exp Biol Med (Maywood). 2022 Jul;247(14):1235-1243. doi: 10.1177/15353702221092672. Epub 2022 Apr 27.

Abstract

Liver fibrosis is the common pathological change of chronic liver diseases characterized by increased deposition of extracellular matrix and reduced matrix degradation. In response to liver injury caused by a variety of pathogenic agents, such as virus and alcohol, hepatic stellate cells (HSCs) are differentiated into myofibroblast-like cells and produce excessive collagens, thus resulting in fibrogenesis. Natural killer (NK) cells are the essential innate immune cells in the liver and generally control fibrosis by killing activated HSCs. This review briefly describes the fibrogenesis process and the phenotypic features of hepatic NK cells. Besides, it focuses on the antifibrotic mechanisms of NK cells and explores the potential of activating NK cells as a therapeutic strategy for the disease.

摘要

肝纤维化是慢性肝病的常见病理变化,其特征是细胞外基质的沉积增加和基质降解减少。针对各种病原体(如病毒和酒精)引起的肝损伤,肝星状细胞(HSCs)分化为肌成纤维细胞样细胞,并产生过量的胶原,从而导致纤维化。自然杀伤(NK)细胞是肝脏中必不可少的固有免疫细胞,通常通过杀死活化的 HSCs 来控制纤维化。本文简要描述了纤维化的发生过程和肝 NK 细胞的表型特征。此外,本文还重点探讨了 NK 细胞的抗纤维化机制,并探讨了激活 NK 细胞作为疾病治疗策略的潜力。

相似文献

1
The antifibrotic role of natural killer cells in liver fibrosis.自然杀伤细胞在肝纤维化中的抗纤维化作用。
Exp Biol Med (Maywood). 2022 Jul;247(14):1235-1243. doi: 10.1177/15353702221092672. Epub 2022 Apr 27.
4
Cell death and fibrogenesis.细胞死亡与纤维化。
Semin Liver Dis. 2010 Aug;30(3):226-31. doi: 10.1055/s-0030-1255352. Epub 2010 Jul 21.
5
Roles and therapeutic targeting of dendritic cells in liver fibrosis.树突状细胞在肝纤维化中的作用及治疗靶点。
J Drug Target. 2024 Jul;32(6):647-654. doi: 10.1080/1061186X.2024.2347365. Epub 2024 Apr 29.

引用本文的文献

6
Non-Classical HLA Class 1b and Hepatocellular Carcinoma.非经典HLA I类分子b与肝细胞癌
Biomedicines. 2023 Jun 9;11(6):1672. doi: 10.3390/biomedicines11061672.
9
Enzymes of Fibrosis in Chronic Liver Disease.慢性肝病中的纤维化酶
Biomedicines. 2022 Dec 8;10(12):3179. doi: 10.3390/biomedicines10123179.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验